Results 271 to 280 of about 6,002,276 (336)

Development of a population pharmacokinetic model using combined paediatric and adult data for four pulmonary arterial hypertension drugs

British Journal of Clinical Pharmacology, EarlyView.
Aims Pulmonary arterial hypertension (PAH) is a syndrome characterized by elevated pulmonary artery pressure. We developed a population pharmacokinetic (PPK) model using combined plasma drug concentration data from Japanese paediatric (<15 years) and adult (≥15 years) patients with PAH to investigate the pharmacokinetic characteristics of PAH ...
Motoyasu Miura, Shimako Tanaka, Ririka Aihara, Shun Yamamoto, Yasumi Nakashima, Yasuharu Kashiwagura, Akio Hakamata, Sachiko Miyakawa, Mariko Tatsuguchi, Keiichi Odagiri, Noriyuki Namiki, Naoki Inui, Hiroshi Watanabe, Shinya Uchida   +13 more
wiley   +1 more source

Association Between Chronic Obstructive Pulmonary Disease Severity and Heart Failure in a Tertiary Care Cohort. [PDF]

Cureus
Malik NUA, Powell JF, Muzaffar J, Zahid KA, Iheukwumere CS, Tayyab M, Hussain Shah SM.   +6 more
europepmc   +1 more source

Semaglutide vs. liraglutide and incidence of diabetes and cardiovascular disease: A target trial emulation using real‐world data

British Journal of Clinical Pharmacology, EarlyView.
Aims The glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) semaglutide and liraglutide are approved for chronic weight management. Both drugs also have favourable effects on the risk of developing diabetes and cardiovascular disease (CVD) compared with placebo, but their comparative effectiveness for these outcomes is unclear.
Ethan J. Cannon, Wendy Wang, Faye L. Norby, Rob F. Walker, Shalini Kulasingam, Lisa S. Chow, Joel F. Farley, Pamela L. Lutsey   +7 more
wiley   +1 more source

Impact of smoking on the treatment cycle and health economics of acute exacerbations of chronic obstructive pulmonary disease. [PDF]

Tob Induc Dis
Li S, Yin L, Lan M, Huang G.
europepmc   +1 more source

Pathogenesis, Diagnostic Advances, and Therapeutic Management of Chronic Obstructive Pulmonary Disease: A Narrative Review. [PDF]

Int J Chron Obstruct Pulmon Dis
Wang S, Han H, Hu X, Hong K.
europepmc   +1 more source

Isoflavone Intake is Associated With Decreased Chronic Obstructive Pulmonary Disease Morbidity. [PDF]

Chronic Obstr Pulm Dis
Belz DC, Quiroz E, Woo H, Jackson MK, Putcha N, Fawzy A, Lorizio W, Hanson CK, Hansel NN.   +8 more
europepmc   +1 more source

Mapping the Comorbidome in Chronic Obstructive Pulmonary Disease: Prevalence and Mortality Risk in a Colombian Cohort. [PDF]

J Clin Med
Faizal Gómez CK, Tuta Quintero E, Bastidas AR, Lozano Forero A, Nieto González MD, Ortíz Marquez V, Herran Pérez MJ, Colmenares Leal AC, Mariño Rodríguez M, Rodríguez Sánchez JC, Cárdenas Rodríguez DS, Perea Gómez FC, Cardona Arango AF, Salamanca España T, Pardo Gallego JD, Restrepo Garzón JR.   +15 more
europepmc   +1 more source

Characteristics of Gut Microbiota in Patients with Chronic Obstructive Pulmonary Disease Based on Metagenomics and Metabolomics. [PDF]

Int J Mol Sci
Wang Y, Liu X, Gao R, An Y, Ren C, An L.
europepmc   +1 more source

Renal Dysfunction in Chronic Obstructive Pulmonary Disease Lung-Kidney Interorgan Crosstalk with Cardiac Mediation. [PDF]

Int J Mol Sci
Dragu R.
europepmc   +1 more source